醫療器械和研究股

5.05k 個跟隨者 • 31 個股票代號追蹤清單由 Yahoo Finance 提供

跟隨此清單即可探索和追蹤醫療器械和研究股。

31 個股票代號

Investor's Business Daily
Dow Jones Futures: Character Change For Market; Oil Prices Pop On Saudi Output Cut
The market sent bullish signals last week. Crude prices jumped as Saudi Arabia cut output. Apple and Palo Alto have big news. Tesla is in a buy zone.
Insider Monkey
10 Internet of Things (IoT) Stocks Billionaires Are Loading Up On
In this piece, we will take a look at the ten internet of things (IoT) stocks billionaires are loading on. For more IoT stocks, head on over to 5 Internet of Things (IoT) Stocks Billionaires Are Loading Up On. As a technology, the consumer use of the Internet is entering its fourth decade. And over […]
Motley Fool
2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip
Dividend Kings are among the most steady corporations on the market. While many businesses don't even last a decade, these companies have survived and thrived and raised their payouts for at least 50 consecutive years to become a member of this elite group. Case in point: Abbott Laboratories (NYSE: ABT) and Johnson & Johnson (NYSE: JNJ) are two members of this prominent clique that have lagged the market recently, partly due to company-specific concerns.
Simply Wall St.
Is Becton, Dickinson and Company's (NYSE:BDX) Recent Stock Performance Influenced By Its Financials In Any Way?
Becton Dickinson's (NYSE:BDX) stock up by 6.6% over the past three months. We wonder if and what role the company's...
Simply Wall St.
Possible Bearish Signals With Danaher Insiders Disposing Stock \
The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...
The Wall Street Journal
Blood-Test Customers Mistakenly Told They May Have Cancer
Grail said its telemedicine vendor sent the inaccurate forms to 400 people because of a software glitch.
Investor's Business Daily
S&P 500 Giant Tesla Leads Five Stocks Near Buy Points As Market Revs Up
The EV giant broke out this week, leading a group of stocks around buy points as the market rally attempts to gather steam.
Motley Fool
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade
Let's consider three stocks that could: Vertex Pharmaceuticals (NASDAQ: VRTX), DexCom (NASDAQ: DXCM), and Amazon (NASDAQ: AMZN). Vertex Pharmaceuticals is doing great things. One of the drugmakers that was closest to entering this market with competing products recently threw in the towel.
Motley Fool
Could AI Boost Growth at Medtronic?
Medtronic (NYSE: MDT) has grown revenue over the years thanks to its solid portfolio of medical devices. Medtronic has taken action, streamlining parts of the business and acquiring assets that could drive future revenue. Medtronic is incorporating AI into its devices more and more.
Zacks
Align Technology (ALGN) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Align Technology (ALGN) closed at $302, marking a +1.62% move from the previous day.
Zacks
Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know
Thermo Fisher Scientific (TMO) closed at $520.14 in the latest trading session, marking a +0.15% move from the prior day.
Reuters
UPDATE 1-Grail says about 400 patients incorrectly informed they may have cancer
Cancer test maker Grail Inc said on Friday that its telemedicine vendor erroneously sent letters to about 400 patients suggesting they may have developed cancer. Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by Illumina Inc, said the letters were mistakenly sent by PWNHealth due to a software issue and that it "was in no way related to or caused by an incorrect Galleri test result".
Reuters
Grail says over 400 patients incorrectly informed they may have cancer
About 400 patients who signed up to take cancer diagnostic test maker Grail's pioneering oncology detection test received erroneous letters suggesting they may have developed cancer, the company said on Friday. Grail's flagship cancer detection blood test Galleri is designed to detect more than 50 types of cancer before symptoms appear. The company, owned by Illumina Inc, said the letters were mistakenly sent by its telemedicine provider PWNHealth due to a software issue and that it "was in no way related to or caused by an incorrect Galleri test result".
Thomson Reuters StreetEvents
Q2 2023 Cooper Companies Inc Earnings Call
Q2 2023 Cooper Companies Inc Earnings Call
Zacks
Illumina's (ILMN) New AI Tool to Predict Genomics Disease
Illumina's (ILMN) PrimateAI-3D will be made broadly available to the genomics community integrated across Illumina Connected Software.
Zacks
Here's Why You Should Retain PacBio (PACB) Stock for Now
PacBio's (PACB) product development activities raise optimism about the stock.
Insider Monkey
S&P 500 Dividend Aristocrats List: Sorted By Hedge Fund Popularity
In this article, we will discuss the best dividend aristocrat stocks sorted by hedge fund popularity. You can skip our detailed analysis of dividend aristocrats and their past performance, and go directly to read S&P 500 Dividend Aristocrats List: Top 10 Among Hedge Funds. Dividend aristocrats are companies in the S&P 500 that have a […]
Zacks
Cooper Companies (COO) Q2 Earnings and Revenues Beat Estimates
Cooper Companies' (COO) second-quarter fiscal 2023 revenues reflect a solid segmental performance despite a year-over-year decline in earnings.
Zacks
Why Is Horizon Therapeutics (HZNP) Down 9% Since Last Earnings Report?
Horizon Therapeutics (HZNP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
PR Newswire
Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Jefferies Global Healthcare Conference. Jim Davis, Chairman, CEO and President, will discuss recent market developments and trends as well as the company's performance and strategy. The presentation is scheduled for Thursday, June 8, 2023, at 2:30 p.m. Eastern Time.
Benzinga
Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction
Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients. PrimateAI-3D utilizes deep neural network architectures similar to ChatGPT and AlphaFold, but is trained on genome sequences rather than human language. After applying the algorithm to half a million genomes in the U.K. Biobank cohort detailing the training, the results showed unprecedented accuracy. The result is a deep neural network that h
Zacks
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and its strategies to accelerate growth.
Business Wire
Agilent Intelligent Mass Spectrometry Solutions to Inspire at ASMS 2023
SANTA CLARA, Calif., June 02, 2023--Agilent Technologies Inc. (NYSE: A) today announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics, being held June 4 - 8 in Houston, Texas. Agilent is a global leader in the mass spectrometry market, providing advanced, intelligent instruments featuring improved analytical performance solutions for analytical labs worldwide.
Reuters
UPDATE 2-Illumina expands board after fight with Icahn
Illumina Inc on Friday said it had expanded its board, adding two C-suite executives a week after shareholders voted to replace the gene sequencing company's chairman with activist investor Carl Icahn's nominee. On Friday it named Stephen MacMillan, CEO of diagnostics products company Hologic Inc, and Scott Ullem, CFO of heart valve systems maker Edwards Lifesciences Corp, as new directors.
Reuters
Illumina expands board after fight with Icahn
On Friday it named Stephen MacMillan, CEO of diagnostics products company Hologic Inc, and Scott Ullem, CFO of heart valve systems maker Edwards Lifesciences Corp, as new directors. Wall Street analysts welcomed the move, with analysts at Evercore ISI writing: "Steve and Scott are well known and respected by Wall Street and should bring a ton of confidence into the (Illumina) story."